DK1625163T3 - Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 - Google Patents
Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43Info
- Publication number
- DK1625163T3 DK1625163T3 DK04732278.9T DK04732278T DK1625163T3 DK 1625163 T3 DK1625163 T3 DK 1625163T3 DK 04732278 T DK04732278 T DK 04732278T DK 1625163 T3 DK1625163 T3 DK 1625163T3
- Authority
- DK
- Denmark
- Prior art keywords
- amino acids
- monoclonal antibody
- antibody binding
- probnp
- native probnp
- Prior art date
Links
- 102100036836 Natriuretic peptides B Human genes 0.000 title abstract 6
- 101710187802 Natriuretic peptides B Proteins 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Cardiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03010591 | 2003-05-12 | ||
| PCT/EP2004/005091 WO2004099252A1 (en) | 2003-05-12 | 2004-05-12 | Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1625163T3 true DK1625163T3 (da) | 2011-12-05 |
Family
ID=33427054
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04732278.9T DK1625163T3 (da) | 2003-05-12 | 2004-05-12 | Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 |
| DK04732282.1T DK1625164T3 (da) | 2003-05-12 | 2004-05-12 | Fremgangsmåde til at påvise proBNP med et monoklonalt antistof, som binder til aminosyrerne 42-46 |
| DK10172014.2T DK2256132T3 (da) | 2003-05-12 | 2004-05-12 | Fremgangsmåde til påvisning af probnp med et monoklonalt antistof |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04732282.1T DK1625164T3 (da) | 2003-05-12 | 2004-05-12 | Fremgangsmåde til at påvise proBNP med et monoklonalt antistof, som binder til aminosyrerne 42-46 |
| DK10172014.2T DK2256132T3 (da) | 2003-05-12 | 2004-05-12 | Fremgangsmåde til påvisning af probnp med et monoklonalt antistof |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US7264939B2 (da) |
| EP (4) | EP2949669A1 (da) |
| JP (4) | JP4430066B2 (da) |
| KR (2) | KR20080011467A (da) |
| CN (3) | CN1784425A (da) |
| AT (2) | ATE522546T1 (da) |
| AU (1) | AU2004235974B2 (da) |
| BR (1) | BRPI0410261B8 (da) |
| CA (2) | CA2522378C (da) |
| DK (3) | DK1625163T3 (da) |
| ES (3) | ES2369008T3 (da) |
| HK (1) | HK1097855A1 (da) |
| HU (1) | HUE025169T2 (da) |
| MX (1) | MXPA05011826A (da) |
| PL (3) | PL1625164T3 (da) |
| WO (2) | WO2004099253A1 (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2843396B1 (fr) * | 2002-08-07 | 2005-04-15 | Bio Rad Pasteur | Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque |
| DK1625163T3 (da) * | 2003-05-12 | 2011-12-05 | Hoffmann La Roche | Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 |
| WO2004105575A2 (en) * | 2003-05-29 | 2004-12-09 | Trustee Of Darmouth College | A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| DE10355731A1 (de) | 2003-11-28 | 2005-06-30 | Roche Diagnostics Gmbh | Analytischer Sandwichtest zur Bestimmung von NT-proBNP |
| ES2288718T3 (es) * | 2004-07-07 | 2008-01-16 | F. Hoffmann-La Roche Ag | Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2. |
| AT500800B1 (de) * | 2004-09-08 | 2008-07-15 | Biomedica Medizinprodukte Gmbh | Verfahren zur bestimmung von probnp |
| WO2008089994A1 (en) | 2007-01-25 | 2008-07-31 | Roche Diagnostics Gmbh | Use of igfbp-7 in the assessment of heart failure |
| KR100836322B1 (ko) * | 2007-08-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 흡음재 제작장치 및 방법 |
| US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
| EP2274622B1 (en) | 2008-04-30 | 2014-10-08 | The Governing Council of the University of Toronto | Use of sfrp-3 in the assessment of heart failure |
| CN102549436A (zh) | 2009-07-27 | 2012-07-04 | 霍夫曼-拉罗奇有限公司 | mimecan在评价心力衰竭中的用途 |
| BR112012011230A2 (pt) * | 2009-11-13 | 2016-04-05 | Bg Medicine Inc | fatores de risco e previsão de infarto do miocárdio |
| AU2011285694B2 (en) | 2010-08-04 | 2014-12-18 | Idexx Laboratories, Inc. | Detection of degradation products of canine NT-proBNP |
| AU2012262154B2 (en) | 2011-05-31 | 2016-08-04 | Idexx Laboratories, Inc. | Detection of degradation products of feline NT-proBNP |
| WO2013042603A1 (ja) * | 2011-09-20 | 2013-03-28 | コニカミノルタホールディングス株式会社 | 検体希釈用液、それを用いたキットおよび蛍光測定方法 |
| US20140273273A1 (en) | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
| CN103304665A (zh) * | 2013-05-21 | 2013-09-18 | 上海贝西生物科技有限公司 | 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用 |
| EP3206032B1 (en) * | 2014-10-10 | 2019-02-27 | Akira Matsumori | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure |
| EP3360570A1 (en) | 2017-02-13 | 2018-08-15 | Roche Diagnostics GmbH | Antibodies recognizing genetic variants |
| JP7203034B2 (ja) * | 2017-10-02 | 2023-01-12 | 大塚製薬株式会社 | アナライトの検出方法 |
| EP3779438A4 (en) * | 2018-04-13 | 2022-01-26 | Kyoritsu Seiyaku Corporation | PROCEDURE FOR DETECTING HEART FAILURE, INSTRUMENT FOR DETECTING HEART FAILURE, SANDWICH IMMUNOASSAY PROCEDURE AND ANTIBODY COMBINATION |
| CN108752480B (zh) * | 2018-05-30 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 一种免疫原组合物、其制备方法及其用途 |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| CN111487222B (zh) * | 2019-01-28 | 2023-11-14 | 上海乐合生物科技有限公司 | 一种检测bnp的spr芯片的制备方法 |
| JP2022544394A (ja) | 2019-08-13 | 2022-10-18 | ゲンティアン アクティーゼルスカブ | Ｎｔ－プロｂｎｐの定量のための高感度粒子増感アッセイ |
| WO2022069658A1 (en) | 2020-09-30 | 2022-04-07 | F. Hoffmann-La Roche Ag | Circulating total-nt-probnp (glycosylated and unglycosylated nt-probnp) and its ratio with nt-probnp (unglycosylated nt-probnp) in the assessment of atrial fibrillation |
| CN112986586A (zh) * | 2021-02-20 | 2021-06-18 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
| CN112964885B (zh) * | 2021-02-20 | 2022-11-11 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
| IL311792A (en) | 2021-10-01 | 2024-05-01 | Gentian As | A new method for determining the concentration of N-terminal prohormone BNP (NT-PROBNP) in a sample |
| WO2023175176A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
| WO2023175152A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
| JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体 |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| GB9827348D0 (en) * | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
| CN101046478B (zh) | 1999-01-29 | 2013-04-03 | 罗赫诊断器材股份有限公司 | 鉴定样品中的n-末端前bnp的方法 |
| US20030219734A1 (en) | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
| US20040096919A1 (en) * | 2002-11-18 | 2004-05-20 | Michelle Davey | Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
| DK1625163T3 (da) * | 2003-05-12 | 2011-12-05 | Hoffmann La Roche | Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 |
-
2004
- 2004-05-12 DK DK04732278.9T patent/DK1625163T3/da active
- 2004-05-12 EP EP15161853.5A patent/EP2949669A1/en not_active Ceased
- 2004-05-12 DK DK04732282.1T patent/DK1625164T3/da active
- 2004-05-12 CA CA2522378A patent/CA2522378C/en not_active Expired - Lifetime
- 2004-05-12 ES ES04732282T patent/ES2369008T3/es not_active Expired - Lifetime
- 2004-05-12 EP EP04732278A patent/EP1625163B8/en not_active Expired - Lifetime
- 2004-05-12 PL PL04732282T patent/PL1625164T3/pl unknown
- 2004-05-12 AU AU2004235974A patent/AU2004235974B2/en not_active Expired
- 2004-05-12 KR KR1020087000782A patent/KR20080011467A/ko not_active Application Discontinuation
- 2004-05-12 JP JP2006505418A patent/JP4430066B2/ja not_active Expired - Lifetime
- 2004-05-12 PL PL10172014T patent/PL2256132T3/pl unknown
- 2004-05-12 KR KR1020057021327A patent/KR100857752B1/ko active IP Right Grant
- 2004-05-12 HU HUE10172014A patent/HUE025169T2/en unknown
- 2004-05-12 WO PCT/EP2004/005092 patent/WO2004099253A1/en active Search and Examination
- 2004-05-12 DK DK10172014.2T patent/DK2256132T3/da active
- 2004-05-12 EP EP10172014.2A patent/EP2256132B1/en not_active Expired - Lifetime
- 2004-05-12 ES ES10172014.2T patent/ES2548327T3/es not_active Expired - Lifetime
- 2004-05-12 CN CNA2004800124973A patent/CN1784425A/zh active Pending
- 2004-05-12 AT AT04732278T patent/ATE522546T1/de active
- 2004-05-12 CA CA2522747A patent/CA2522747C/en not_active Expired - Lifetime
- 2004-05-12 AT AT04732282T patent/ATE517124T1/de active
- 2004-05-12 PL PL04732278T patent/PL1625163T3/pl unknown
- 2004-05-12 WO PCT/EP2004/005091 patent/WO2004099252A1/en active Application Filing
- 2004-05-12 CN CN2010101190838A patent/CN101967190A/zh active Pending
- 2004-05-12 EP EP04732282A patent/EP1625164B1/en not_active Expired - Lifetime
- 2004-05-12 JP JP2006505419A patent/JP5128125B2/ja not_active Expired - Lifetime
- 2004-05-12 ES ES04732278T patent/ES2372282T3/es not_active Expired - Lifetime
- 2004-05-12 CN CNB200480012494XA patent/CN100497393C/zh not_active Expired - Lifetime
- 2004-05-12 BR BRPI0410261A patent/BRPI0410261B8/pt active IP Right Grant
- 2004-05-12 MX MXPA05011826A patent/MXPA05011826A/es active IP Right Grant
-
2005
- 2005-11-10 US US11/271,651 patent/US7264939B2/en not_active Expired - Lifetime
- 2005-11-10 US US11/271,138 patent/US7264938B2/en not_active Expired - Lifetime
-
2006
- 2006-12-05 US US11/634,286 patent/US7807380B2/en not_active Expired - Lifetime
- 2006-12-22 US US11/644,565 patent/US7811770B2/en not_active Expired - Lifetime
-
2007
- 2007-02-28 HK HK07102250.4A patent/HK1097855A1/xx not_active IP Right Cessation
-
2009
- 2009-09-04 JP JP2009204610A patent/JP4834136B2/ja not_active Expired - Lifetime
-
2012
- 2012-10-04 JP JP2012222436A patent/JP5649631B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1625163T3 (da) | Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 | |
| DE602004001533D1 (de) | Immunotestverfahren für Herz-Troponin I | |
| ATE440868T1 (de) | Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen | |
| ATE486093T1 (de) | Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt | |
| WO2004046194A3 (en) | Polyclonal-monoclonal elisa assay for detecting n-terminus probnp | |
| JP2007525427A5 (da) | ||
| DK1092155T3 (da) | Fremgangsmåde til tidlig diagnose af carcinomer | |
| DK1151304T3 (da) | Fremgangsmåde til påvisning af N-terminalt proBNP | |
| RS54113B1 (en) | COMPOSITIONS AND PROCEDURES FOR ANTIBODIES ON THE C5 COMPLEMENTARY PROTEIN | |
| DK1579222T3 (da) | Ikke-kompetitivt immunassay til små analytter | |
| ATE335763T1 (de) | Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden | |
| ATE487946T1 (de) | Analytischer sandwichtest zur bestimmung von nt- probnp | |
| DE60333471D1 (de) | Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp | |
| ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
| DK2185937T3 (da) | Fremgangsmåde til at bestemme sepsis hos mennesker | |
| BRPI0820885B8 (pt) | "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)". | |
| RU2018103933A (ru) | Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом | |
| DK1400589T3 (da) | Fremgangsmåde til påvisning af prokaryotisk DNA | |
| WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
| WO2009044561A1 (ja) | 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体 | |
| DE60229043D1 (de) | Rearrangierte plattenepithelkarzinomantigen-gene ii | |
| DK1539817T3 (da) | Immunoassays til specifik bestemmelse af SCCA-isoformer | |
| ATE491949T1 (de) | Immunnachweiskit in verbindung mit neuroglobin- enzym sowie verwendung davon | |
| EP1359161A3 (en) | Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof | |
| DE502006005985D1 (de) | Testsystem zum nachweis von salmonellen |